Wegovy Side Effects and UTI: Separating Fact from Common Concern

Step 1: Understand what's actually in the safety data

The Wegovy (semaglutide) SmPC, published on the Electronic Medicines Compendium, lists urinary tract infection under the frequency category 'uncommon', meaning it was recorded in between 1 in 1,000 and 1 in 100 trial participants. For context, the NHS patient information for semaglutide focuses its side-effect guidance on the gastrointestinal symptoms that affected the majority of people in clinical trials: nausea, vomiting, diarrhoea, constipation and indigestion. UTIs sit well down the frequency list.

This matters because the internet has a way of amplifying uncommon effects. If you're reading accounts online of people experiencing UTIs on Wegovy, you're likely seeing a reporting pattern rather than a common clinical pattern. The STEP 1 trial, which enrolled over 1,900 adults across 68 weeks, did not identify UTI as a prominent adverse event at the 2.4mg dose. So while the association cannot be dismissed (it is in the regulatory documentation) it is not one of the defining features of semaglutide's side-effect profile.

You can read more about the broader picture of Wegovy side effects if you want to understand where UTI sits relative to everything else.

Step 2: Consider the indirect mechanisms that might increase risk

One question worth sitting with: even if semaglutide does not directly cause UTIs through its pharmacology, could it create conditions that make them more likely? There are a few plausible pathways worth understanding.

First, dehydration. Nausea and vomiting (which are common in the early weeks of treatment, particularly around dose increases) can reduce fluid intake significantly. Lower fluid throughput means less frequent urination, and less frequent urination means bacteria have longer to establish themselves in the urinary tract. This is not unique to Wegovy; it applies to any illness or medicine that reduces how much you drink or how much you keep down. The practical implication is straightforward: prioritising hydration, especially in the first weeks at each new dose, is sensible. Small, regular sips rather than trying to drink a large volume at once often works better when nausea is present.

Second, blood glucose effects. Semaglutide is also used in the management of type 2 diabetes, and elevated glucose can increase UTI susceptibility. If you have diabetes or pre-diabetes alongside your weight-management treatment, this interaction is worth discussing with your prescriber. Our FAQs address several common questions about semaglutide in different clinical situations.

It's also worth knowing that some people taking Wegovy experience no side effects at all, the response is genuinely variable.

Step 3: Recognise when urinary symptoms need medical attention today

If you're experiencing UTI symptoms while taking Wegovy, honest acknowledgement first: it's unsettling to deal with a new symptom when you're already managing a medication change, and the last thing most people want is another trip to a clinic. That frustration is understandable. But the triage here matters, and it's not complicated.

Simple lower UTI symptoms (burning or stinging when urinating, increased urgency, cloudy or strong-smelling urine) are usually manageable with a GP consultation or, in many areas, a pharmacist assessment. They are not a reason to stop your Wegovy without speaking to your prescriber first.

The symptoms that need same-day medical attention, however, are different: fever above 38°C, chills, rigors, pain or aching in the back or sides (flank pain), nausea and vomiting alongside urinary symptoms, or any sense that you feel significantly unwell. These can signal a kidney infection (pyelonephritis), which is a more serious condition requiring prompt treatment. Do not wait. Go to your GP urgently, or to urgent care if your surgery is closed.

The MHRA Yellow Card scheme is there for anyone who wants to report a suspected side effect (including urinary symptoms) while on any medicine. Reports from real patients are genuinely valuable to the regulator's ongoing monitoring. If you want to understand how long Wegovy side effects tend to last, that page covers the typical timelines in more detail.

Step 4: Talk to a prescriber before making any changes

One of the most common mistakes people make when they experience an unexpected symptom is adjusting their medication on their own, skipping a dose, staying at their current dose longer than planned, or stopping altogether. For a prescription medicine, these decisions belong with a clinician. The full Wegovy treatment overview explains how semaglutide works and what the prescribing structure looks like; it's a useful reference if you want context before a consultation.

At nume, every repeat order is reviewed by a real prescriber before it's dispensed. If something has changed since your last dose (a new symptom, a new medicine, anything that gives you pause) that review is the moment to raise it. Our clinical team is available for aftercare queries seven days a week. If you're thinking about starting treatment and want a full picture of what side effects from Wegovy people commonly report before you begin, that page covers the early experience in detail alongside the most frequently reported effects.

Semaglutide is a prescription-only medicine. A prescriber decides suitability, monitors progress and helps you make sense of anything unexpected. If you're considering starting, our prescribers discuss side effects as part of the free consultation, no commitment required to speak to someone qualified.